Cargando…
Response to comments on: Two-year clinical outcomes following lower limb endovascular revascularisation for chronic limb-threatening ischaemia at a tertiary Asian vascular centre in Singapore
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584065/ https://www.ncbi.nlm.nih.gov/pubmed/36259574 http://dx.doi.org/10.4103/singaporemedj.SMJ-2022-142 |
_version_ | 1784813197054705664 |
---|---|
author | Lee, Rui En Yap, Charyl Jia Qi Tang, Tjun Yip |
author_facet | Lee, Rui En Yap, Charyl Jia Qi Tang, Tjun Yip |
author_sort | Lee, Rui En |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9584065 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-95840652022-10-21 Response to comments on: Two-year clinical outcomes following lower limb endovascular revascularisation for chronic limb-threatening ischaemia at a tertiary Asian vascular centre in Singapore Lee, Rui En Yap, Charyl Jia Qi Tang, Tjun Yip Singapore Med J Letter to the Editor Wolters Kluwer - Medknow 2022-09-30 /pmc/articles/PMC9584065/ /pubmed/36259574 http://dx.doi.org/10.4103/singaporemedj.SMJ-2022-142 Text en Copyright: © 2022 Singapore Medical Journal https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Letter to the Editor Lee, Rui En Yap, Charyl Jia Qi Tang, Tjun Yip Response to comments on: Two-year clinical outcomes following lower limb endovascular revascularisation for chronic limb-threatening ischaemia at a tertiary Asian vascular centre in Singapore |
title | Response to comments on: Two-year clinical outcomes following lower limb endovascular revascularisation for chronic limb-threatening ischaemia at a tertiary Asian vascular centre in Singapore |
title_full | Response to comments on: Two-year clinical outcomes following lower limb endovascular revascularisation for chronic limb-threatening ischaemia at a tertiary Asian vascular centre in Singapore |
title_fullStr | Response to comments on: Two-year clinical outcomes following lower limb endovascular revascularisation for chronic limb-threatening ischaemia at a tertiary Asian vascular centre in Singapore |
title_full_unstemmed | Response to comments on: Two-year clinical outcomes following lower limb endovascular revascularisation for chronic limb-threatening ischaemia at a tertiary Asian vascular centre in Singapore |
title_short | Response to comments on: Two-year clinical outcomes following lower limb endovascular revascularisation for chronic limb-threatening ischaemia at a tertiary Asian vascular centre in Singapore |
title_sort | response to comments on: two-year clinical outcomes following lower limb endovascular revascularisation for chronic limb-threatening ischaemia at a tertiary asian vascular centre in singapore |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584065/ https://www.ncbi.nlm.nih.gov/pubmed/36259574 http://dx.doi.org/10.4103/singaporemedj.SMJ-2022-142 |
work_keys_str_mv | AT leeruien responsetocommentsontwoyearclinicaloutcomesfollowinglowerlimbendovascularrevascularisationforchroniclimbthreateningischaemiaatatertiaryasianvascularcentreinsingapore AT yapcharyljiaqi responsetocommentsontwoyearclinicaloutcomesfollowinglowerlimbendovascularrevascularisationforchroniclimbthreateningischaemiaatatertiaryasianvascularcentreinsingapore AT tangtjunyip responsetocommentsontwoyearclinicaloutcomesfollowinglowerlimbendovascularrevascularisationforchroniclimbthreateningischaemiaatatertiaryasianvascularcentreinsingapore |